Risk stratification and prognostic factors in patients with unresectable undifferentiated carcinoma of the pancreas
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Pancreatology
- Vol. 21 (4) , 738-745
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The presence of a cytopathologist increases the diagnostic accuracy of endoscopic ultrasound‐guided fine needle aspiration cytology for pancreatic adenocarcinoma: a meta‐analysisCytopathology, 2013
- How Good Is Endoscopic Ultrasound–Guided Fine-Needle Aspiration in Diagnosing the Correct Etiology for a Solid Pancreatic Mass?Pancreas, 2013
- EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysisGastrointestinal Endoscopy, 2012
- Anaplastic pancreatic cancer: Presentation, surgical management, and outcomeSurgery, 2011
- Complete response of anaplastic pancreatic carcinoma to paclitaxel treatment selected by chemosensitivity testingInternational Journal of Clinical Oncology, 2010
- Changing Incidence of Pancreatic NeoplasmsPancreas, 2008
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative GroupJournal of Clinical Oncology, 2008
- Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancerInternational Journal of Colorectal Disease, 2007
- A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literatureAnnals of Diagnostic Pathology, 2001
- Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical casesHistopathology, 1983